Program
Scope
The World Congress on Interventional Therapies for Type 2 Diabetes is a comprehensive, multidisciplinary forum where leading international experts will conduct a critical review and discussion of the latest research findings on metabolic/bariatric surgery and novel interventional therapies for type 2 diabetes.
The signature design of this congress includes state-of-the art review lectures and debates among clinicians, scientists, and policy makers.
The overarching aim is to craft an agenda of research priorities and health policy initiatives relevant to the use and study of gastrointestinal interventions, with the ultimate goal of improving the treatment and understanding of diabetes and providing direction for treatments of curative intent.
Specific themes of the World Congress include:
- Epidemiology and economic impact of diabetes
- Latest research findings on interventional therapies for type 2 diabetes
- Current recommendations/guidelines for surgical treatment of diabetes
- Impact of interventional therapies on cardiovascular risk in diabetic patients
- Role of integrated surgical and medical approaches for diabetes (multimodality therapies)
- Novel technologies and gastrointestinal devices for diabetes
- Cost effectiveness of surgery as a treatment for diabetes
- Conventional paradigms vs. novel ideas on the etiology of diabetes and obesity: debate by leading scientists in the field
- Mechanisms of surgical control of diabetes and gastrointestinal targets for drug development
Who Should Attend?
This Congress is designed for professionals in the fields of endocrinology, diabetes, bariatric/metabolic surgery, cardiology, epidemiology, gastroenterology, internal medicine, family medicine, pharmacology, nutrition, basic science, and public health, as well as allied health professionals, policy makers, and scientists from the pharmaceutical and medical device industries.